Shanghai Sonyt Biotechnology Co., Ltd. is one of the leading manufacturers and suppliers of cas 61370-88-5 [des-tyr1]-met-enkephalin in China, also supports custom service. Welcome to wholesale bulk high quality cas 61370-88-5 [des-tyr1]-met-enkephalin from our factory. Contact us for more details.
| Description | Removing the essential N-terminal Tyr abolishes opioid receptor binding, serving as a negative control for enkephalin structure-activity studies. |
Product Basic Information Table
| Standard English Name | Abbreviation/Synonym | Function Tags (comma-separated) | Core Structure | Molecular Formula | Exact Mass (Da) | Average MW (Da) | Salt Form | Length (aa) |
| [Des-Tyr1]-Met-Enkephalin, CAS 61370-88-5 | [Des-Tyr1]-Met-enkephalin; des-tyrosyl(1)-methionine enkephalin; beta-lipotropin (62-65); Gly-Gly-Phe-Met; GGFM-OH; PEP-DTME-01 | endogenous opioid peptide, enkephalin degradation product, delta-opioid receptor ligand, tetrapeptide, Met-containing, C-terminal free acid | 4-residue linear short peptide, H-Gly-Gly-Phe-Met-OH (GGFM); free N-terminal glycine and C-terminal free acid (Met-COOH); no C-terminal amide, no N-acetylation, no disulfide. Contains Met×1 (C-terminal), Phe×1, Gly×2; no Tyr, Trp or Cys. This is the Met-enkephalin (Tyr-Gly-Gly-Phe-Met, YGGFM) derivative lacking the N-terminal Tyr1 (corresponding to beta-lipotropin residues 62–65); do not confuse with the parent Met-enkephalin (YGGFM) or Leu-enkephalin (YGGFL). | C18H26N4O5S | 410.16 | 410.49 | Free peptide (short peptides are often supplied as free base or TFA salt; the counterion is excluded from the main-chain formula; actual salt form and acid stoichiometry are per lot COA). | 4 |
Physicochemical Solubility & Storage Parameters
| Product Code | Appearance | Long-term Storage | Short-term Storage | Solution Stability | Solid Powder Stability |
| PEP-DTME-01 | White to off-white powder (hydrophilic short peptide; if supplied as TFA salt it is hygroscopic - reseal immediately after opening, keep in a desiccator and weigh rapidly). | Store sealed, dry and light-protected at −20°C. Contains Met×1 - purge inert gas (Ar/N2) against oxidation and avoid air exposure; the short peptide is structurally stable. No Cys/disulfide, so no reducing-agent restriction; no Trp/Tyr, so no dedicated photodegradation risk, keep routinely light-protected. Protect the salt form from moisture. | Store dry and light-protected at 2–8°C; use within 2–4 weeks; store working aliquots frozen at −20°C. | Hydrophilic short peptide; soluble in water, saline or neutral buffer. If dissolution is difficult, pre-dissolve in a small amount of DMSO then dilute with buffer; initial concentration ≤10 mg/mL is recommended. After reconstitution: ≤1 week at 2–8°C; aliquot and freeze ≤3 months at −20°C; ≤3 freeze-thaw cycles; protect Met from repeated air/oxidant exposure; no Cys, so reducing agents are not restricted; avoid pH>8. | Dry-sealed, stable for at least 2 years at 2–8°C; longer-term storage at −20°C; keep moisture- and oxidation-protected. |
Functional Description
| Product Code | Front-end Short Summary | Detailed Biological Function | Research Areas (comma-separated) | Targets / Receptors |
| PEP-DTME-01 | [Des-Tyr1]-Met-enkephalin, a 4-mer (GGFM-OH), CAS 61370-88-5, C-terminal free acid; formula C18H26N4O5S, MW 410.16/410.49. A Met-enkephalin derivative lacking the N-terminal Tyr, it is a weak delta-opioid receptor ligand used in opioid-peptide degradation and receptor-ligand research. | This peptide is the Met-enkephalin (YGGFM) degradation fragment lacking the N-terminal tyrosine, belonging to the endogenous opioid peptide family and corresponding to beta-lipotropin residues 62–65. The N-terminal aromatic Tyr is a key pharmacophore for opioid receptor binding; after Tyr1 removal, affinity for the mu-opioid receptor (MOR) drops markedly, while binding to the delta-opioid receptor (DOR/OPRD1, Gi/o-coupled: inhibits adenylyl cyclase, lowers intracellular cAMP, and modulates K+/Ca2+ channels and neuronal membrane potential) is largely retained. Its analgesic, anti-inflammatory and gut-motility effects are weaker than those of the parent enkephalin, and it participates in pain and emotional homeostasis. Applications include opioid-peptide metabolism/degradation pathways, DOR ligand SAR, and pain/neuropeptide mechanism research. Structure verification: the CAS 61370-88-5 catalog entry lists sequence GGFM, free acid, formula C18H26N4O5S, MW ≈410.5; KEGG C11684 (parent Met-enkephalin, YGGFM, CAS 58569-55-4) corroborates that removal of Tyr1 yields GGFM. Recalculated 410.16/410.49 Da, within 0.05 Da of external references. | opioid peptide and analgesia research, delta-opioid receptor ligand, neuropeptide metabolism and degradation, GPCR research, pain and emotional homeostasis | Delta-opioid receptor (DOR/OPRD1, Gi/o-coupled GPCR); low affinity for the mu-opioid receptor (MOR/OPRM1). |
Hot Tags: cas 61370-88-5 [des-tyr1]-met-enkephalin, China cas 61370-88-5 [des-tyr1]-met-enkephalin manufacturers, suppliers, factory, 23815-91-0, 25696-21-3, Bradykinin 1 3 , CAS 76461 17 1, hormone peptide, Somatostatin-25
![CAS 61370-88-5 [Des-Tyr1]-Met-Enkephalin](/uploads/48442/cas-61370-88-5-des-tyr1-met-enkephalin81be1.jpg)